When comparing the CSF-metabolome profiles of patients with IDH-mutated glioma and those with wild-type glioma, 18 metabolites showed considerable differences in concentration according to the volcano plot (FC and raw p value) (Fig. 5A). This evidence concerns the gene IDH1 and central nervous system cancer.